BioBoston Consulting

Audit Gap Assessments and CAPA Planning for Life Sciences Companies

GxP audit gap assessment process

Building a Foundation for Continuous Compliance  In the fast-evolving world of Pharmaceuticals, Biotechnology, and Medical devices, regulatory expectations are becoming more rigorous than ever. To stay competitive and compliant, organizations must continuously evaluate their systems and processes against GxP and cGMP standards.  Audit gap assessments and CAPA (Corrective and Preventive Action) planning are essential tools that help life sciences companies maintain a robust Quality Management System (QMS), ensure FDA and […]